Cargando…

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization

Detalles Bibliográficos
Autores principales:	Andrabi, Raiees, Bala, Manju, Kumar, Rajesh, Hazarika, Anjali, Luthra, Kalpana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344812/ http://dx.doi.org/10.1186/1471-2334-12-S1-O19

Ejemplares similares

Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India
por: Andrabi, Raiees, et al.
Publicado: (2012)

A comprehensive binding and neutralization analysis of plasma of HIV-1 subtype-C infected donors from India suggest MPER directed neutralization
por: Andrabi, R, et al.
Publicado: (2012)

Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses
por: Yi, Guohua, et al.
Publicado: (2013)

Cross-clade neutralization potential of the plasma of antiretroviral naïve HIV-1 infected children from north India
por: Sankaran, Prakash Somi, et al.
Publicado: (2012)

Neutralization tiers of HIV-1
por: Montefiori, David C., et al.
Publicado: (2018)

Relative reduction of plasmacytoid dendritic cells with shift in TH(1) to TH(2) response in HIV-1 infected patients as compared to high risk and healthy north Indians
por: Chaudhary, Omkar, et al.
Publicado: (2012)

Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
por: Andrabi, Raiees, et al.
Publicado: (2012)

Correction: Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses
por: Yi, Guohua, et al.
Publicado: (2013)

Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual
por: Khan, Lubina, et al.
Publicado: (2015)

An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Cross clade reactive plasma anti-V3 antibodies in human immunodeficiency virus type-1 infected individuals develop with time
por: Andrabi, Raiees, et al.
Publicado: (2012)

Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor
por: Andrabi, Raiees, et al.
Publicado: (2013)

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
por: Pinto, Dora, et al.
Publicado: (2019)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
por: Ruprecht, Claudia R., et al.
Publicado: (2011)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8
por: Soto, Cinque, et al.
Publicado: (2016)

An MPER antibody neutralizes HIV-1 using germline features shared among donors
por: Zhang, Lei, et al.
Publicado: (2019)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2014)

Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design
por: Wieczorek, L, et al.
Publicado: (2012)

Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization
por: Kim, Arthur S., et al.
Publicado: (2014)

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
por: Molinos-Albert, Luis M, et al.
Publicado: (2014)

Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA
por: Krebs, Shelly J., et al.
Publicado: (2014)

CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children
por: Kumar, Sanjeev, et al.
Publicado: (2017)

Production and expression of recombinant anti-V3 scFvs from HIV-1 clade C infected Indian patient
por: Kumar, Rajesh, et al.
Publicado: (2012)

P04-37. Kinetic and thermodynamic factors determine HIV-1 neutralizing potency of MPER-specific antibodies
por: Ruprecht, C, et al.
Publicado: (2009)

Correction: Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA
Publicado: (2015)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)

P19-50. Simulation of an MPER peptide samples epitope conformations of two broadly neutralizing antibodies
por: Wiehe, K, et al.
Publicado: (2009)

Plasma antibodies that cross react to subtype-B and C third variable (V3) region develop in Indian HIV-1 infected iIndividuals with time
por: Andrabi, R, et al.
Publicado: (2012)

HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier
por: Bell, Benjamin N., et al.
Publicado: (2023)

Production of cross neutralizing single chain fragment variables (scFv) from HIV-1 infected Indian children
por: Kumar, Sanjeev, et al.
Publicado: (2014)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
por: Gray, E, et al.
Publicado: (2009)

Deep sequencing reveals an association between HIV-1 subtype C mutations in gp41 MPER epitopes and mother-to-child transmission
por: Yin, L, et al.
Publicado: (2012)

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
por: Mishra, Nitesh, et al.
Publicado: (2021)

Maturation-Induced Cloaking of Neutralization Epitopes on HIV-1 Particles
por: Joyner, Amanda S., et al.
Publicado: (2011)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
por: Ferguson, Andrew L., et al.
Publicado: (2013)

Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure
por: Ray, Krishanu, et al.
Publicado: (2019)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
por: Jacob, RA, et al.
Publicado: (2012)

Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines
por: Ye, Ling, et al.
Publicado: (2011)

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_367bl0oh5j317l5ddmqe47c3dl